Impact of pre‐transplant dialysis modality on post‐transplant diabetes mellitus after kidney transplantation

Cécile Courivaud, Marc Ladrière, Olivier Toupance, Sophie Caillard, Bruno Hurault de Ligny, Jean‐Philippe Ryckelynck, Bruno Moulin, Philippe Rieu, Luc Frimat, Jean‐Marc Chalopin,

Clinical Transplantation · 2010 · 39 citations · 20 references

Concepts

Abstract

Courivaud C, Ladrière M, Toupance O, Caillard S, de Ligny BH, Ryckelynck J‐P, Moulin B, Rieu P, Frimat L, Chalopin J‐M, Chauvé S, Kazory A, Ducloux D. Impact of pre‐transplant dialysis modality on post‐transplant diabetes mellitus after kidney transplantation. Clin Transplant 2011: 25: 794–799. © 2010 John Wiley & Sons A/S. Abstract: Post‐transplant diabetes mellitus (PTDM) is a well‐known complication in renal transplant recipients (RTRs). While a number of risk factors for PTDM have been identified, the potential impact of pre‐transplant dialysis modality on subsequent development of PTDM has not yet been explored. We performed a multicenter retrospective study on 2010 consecutive RTRs who did not have a history of diabetes prior to renal transplantation. PTDM was defined as a need for anti‐diabetic therapy in an RTR without a history of diabetes prior to transplantation. Analysis of the risk factors for development of PTDM was performed with respect to pre‐transplant dialysis modality. A total of 137 (6.8%) patients developed PTDM; 7% in the hemodialysis group and 6.5% in the peritoneal dialysis (PD) group (p = 0.85). In the multivariate analysis, age (p < 0.001), body mass index (BMI) (p < 0.001), use of tacrolimus (p = 0.002), and rejection episodes (p < 0.001) were identified as independent risk factors for development of PTDM. Patients in the PD group were younger (p = 0.004), had lower BMI (p = 0.07), and were less likely to have a history of hepatitis C (p = 0.007) and autosomal dominant polycystic kidney disease (p = 0.07). Adjustment for these variables did not modify the results. The results of this study suggest that pre‐transplant dialysis modality does not have an impact on the subsequent development of PTDM in RTRs.

References

20